Psoriatic Arthritis (PsA) Treatment Market Analysis

Psoriatic Arthritis (PsA) Treatment Market: Patent Expiration of Blockbuster Disease Modifying Antirheumatic Drugs and Approval of Biosimilar Drugs to Propel Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

  • 193 pages
  • PDF PPT EXCEL
Psoriatic Arthritis (PsA) Treatment Market Analysis
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Psoriatic Arthritis (PsA) Treatment: Unlocking the Potential of Biosimilars

Psoriatic Arthritis (PsA) treatment continues to gain high demand due to the launch of biologics & biosimilar therapies, and the growing adoption of novel treatments. In the recent years, manufacturers have renewed their focus on strategic collaborations for the development of biosimilars and the expansion of their businesses in emerging markets. The global demand for Psoriatic Arthritis (PsA) treatment is rising as a result of the launch of biosimilars that are undergoing clinical trial programs.

Market Set to Grow by 2.0X between 2018 and 2028

The Psoriatic Arthritis (PsA) treatment market is likely to witness steady growth over the course of the forecast period, which is expected to be driven by the increasing prevalence of Psoriatic Arthritis (PsA) across the world, and increasing clinical research for the development of new drugs for the treatment of psoriatic arthritis. Furthermore, increase in funding for research and development is another factor shaping the economic growth, which is also contributing to the growth of the Psoriatic Arthritis (PsA) treatment market.

Emerging Countries Promise New Opportunities for the Growth of Biosimilars

North America is expected to contribute the highest revenue share in the global Psoriatic Arthritis (PsA) treatment market in 2019. However, healthy growth is expected in developed and developing regions, especially Europe and Asia Pacific, as governments and private players in these regions are focusing on developing novel therapies for the treatment of Psoriatic Arthritis (PsA). Among the emerging countries, India and China are likely to present sustainable growth opportunities for stakeholders in the Psoriatic Arthritis (PsA) treatment market. Due to strong growth of India and China, the Asia Pacific region is likely to emerge as a lucrative market during the forecast period.

* This data is only a representation. Actual data may vary and will be available in report.

Emerging Countries Promise New Opportunities for the Growth of Biosimilars
Emerging Countries Promise New Opportunities for the Growth of Biosimilars
Emerging Countries Promise New Opportunities for the Growth of Biosimilars
Emerging Countries Promise New Opportunities for the Growth of Biosimilars
  • 2014
  • 2018
  • 2022
  • 2028
  • Arrow

The Broader Perspective

Stakeholders in the Psoriatic Arthritis (PsA) treatment market are focusing on developing new oral treatments with the potential to benefit psoriatic arthritis patients, which further increases the adoption of oral treatments. Manufacturers are focusing on offering effective products by using a combination of drugs such as nonsteroidal anti-inflammatory drugs and disease-modifying anti-rheumatic drugs. Investments in R&D are expected to continue to grow during the assessment period.

Biologics remains the top-selling category in the drug type, and are expected to witness relatively high growth during the forecast period

Disease-Modifying Anti-rheumatic Drugs are likely to grow at a moderate rate

The Non-steroidal Anti-inflammatory Drugs drug type is likely to witness slow growth

The oral route of administration likely to growth at a slow rate during the forecast period

The injectable route of administration accounts for more than three-fourth share of the total revenue due to the higher adoption of injectables

Hospital pharmacies remain among the prominent distribution channels with a revenue share of nearly 40%

Demand from mail order pharmacies is expected to grow at a rapid rate

How Growth will Unfold

The biologics segment is expected to maintain its leading position over other drug types during the assessment period, whereas the disease-modifying anti-rheumatic drugs segment is expected to grow at a moderate growth rate.

Nonsteroidal Anti-inflammatory Drugs | Disease-Modifying Antirheumatic Drugs | Biologics

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Read in-depth analysis on Psoriatic Arthritis (PsA) Treatment Market Analysis

Overview

Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis 2013–2017 and Forecast 2018–2028

A recent market study published by FMI “Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis 2013–2017 and Forecast 2018–2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the psoriatic arthritis (PsA) treatment market, the growth prospects of the market are obtained with maximum precision.

Psoriatic Arthritis Psa Treatment Market Taxonomy

The global psoriatic arthritis (PsA) treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Product

  • Non-steroidal anti-inflammatory drugs
  • Disease modifying Anti-rheumatic drugs
    • Corticosteroids
    • Antimalarial
    • Methotrexate
    • Others
  • Biologics
    • TNF Inhibitors
    • Interleukin inhibitors

By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital pharmacies,
  • Retail pharmacies,
  • Mail order pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

What's Included

The report commences with the executive summary of the psoriatic arthritis (PsA) treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments in the psoriatic arthritis (PsA) treatment market.

Readers can find a detailed taxonomy and the definition of the psoriatic arthritis (PsA) treatment market in this chapter, which will help them better understand the basic information about the psoriatic arthritis (PsA) treatment market dynamics, clinical trials, average cost of treatment, and key regulations that have been included in the report.

Based on product type, the psoriatic arthritis (PsA) treatment market is segmented into nonsteroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, and biologics. Disease modifying antirheumatic drugs are further sub-segmented into corticosteroids, antimalarial, methotrexate, and others. Biologics are further sub-segmented into TNF Inhibitors and interleukin inhibitors. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on product type for each region.

Based on distribution channel, the psoriatic arthritis (PsA) treatment market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on distribution channel for each region.

Based on route of administration, the psoriatic arthritis (PsA) treatment market is segmented into oral and injectable. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on route of administration in each region.

This chapter explains how the psoriatic arthritis (PsA) treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

This chapter includes detailed analysis of the growth of the North America psoriatic arthritis (PsA) treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, route of administration, distribution channel, and country in the psoriatic arthritis (PsA) treatment market of North America.

Readers can find detailed information about factors such as regional trends that are impacting the growth of the Latin America psoriatic arthritis (PsA) treatment market. This chapter also includes the growth prospects of the psoriatic arthritis (PsA) treatment market in leading LATAM countries such as Mexico, Brazil, and the rest of the Latin American region.

Important growth prospects of the psoriatic arthritis (PsA) treatment market based on its product type, distribution channel, and route of administration in several countries such as the U.K., Germany, Spain, Italy, France, Russia, and the rest of Europe are included in this chapter.

Japan, India, China, Australia, and the rest of APAC are the leading countries in the APAC region that are the prime subject of assessment to obtain the growth prospects of the APEC psoriatic arthritis (PsA) treatment market, in this chapter. Readers can find thorough information about the growth parameters of the APAC psoriatic arthritis (PsA) treatment market during the period 2018-2028.

This chapter provides information on how the psoriatic arthritis (PsA) treatment market will grow in major countries in the MEA region, such as GCC countries, South Africa, and the rest of MEA, during the period 2018-2028.

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the psoriatic arthritis (PsA) treatment market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The market players that have been featured in the report include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, UCB S.A., Eli Lilly & Co, Novartis AG, Celgene Corporation, and AstraZeneca PLC, among others.

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the psoriatic arthritis (PsA) treatment market.

How the research was conducted?

Primary Research

Primary research interview with Key Opinion Leaders and other participants were conducted for data collection and validation of the below information:

  • High Prevalence by Gender and Age-Group
  • Treatment Seeking Rate
  • Adoption of Non-steroidal anti-inflammatory drugs injection as mode of treatment
  • Average Dosage Pattern per Patient
  • Average Selling Price (US$) and Market Growth
  • Key Developments
  • Key Trends and Opportunities
  • Regional wise Dynamics
  • Reimbursement Landscape
  • Market Share Information
  • Key Brands
  • Competition & Key Vendor Strategies

Secondary Research

  • National Psoriasis Foundation/USA
  • The Arthritis Society
  • NHS
  • Mayo Foundation
  • The Cleveland Clinic Foundation
  • National Psoriasis Foundation
  • Psoriatic arthritis - Arthritis Research UK
  • Johns Hopkins Arthritis Center
  • Spondylitis Association of America
  • American Academy of Dermatology.
  • U.S. Food and Drug Administration
  • American College of Rheumatology
  • Arthritis Australia
  • Cedars-Sinai
  • Merck Sharp & Dohme Corp.,
  • Harvard University
  • American College of Rheumatology
  • ARTHRITIS FOUNDATION
  • Annual Reports/SEC filings/Investor Presentations/Earning Call Transcript
  • Industry Journals

Primary Interview Splits

Primary Research Interview Splits

Psoriatic Arthritis Psa Treatment Market Reports - Table of Contents

  1. Global Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  2. Global Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  3. Global Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  4. Global Psoriatic Arthritis Treatment Market Value Share By Region (2018E)

  5. North America Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  6. North America Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  7. North America Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  8. North America Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  9. North America Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  10. North America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  11. U.S. Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  12. U.S. Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  13. Canada Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  14. Canada Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  15. North America Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  16. North America Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  17. North America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  18. North America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  19. North America Biologics Market Size (US$ Mn) Analysis, 2013–2017

  20. North America Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  21. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  22. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  23. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  24. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  25. Latin America Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  26. Latin America Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  27. Latin America Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  28. Latin America Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  29. Latin America Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  30. Latin America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  31. Mexico Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  32. Mexico Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  33. Brazil Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  34. Brazil Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  35. Rest of Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  36. Rest of Latin America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  37. Latin America Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  38. Latin America Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  39. Latin America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  40. Latin America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  41. Latin America Biologics Market Size (US$ Mn) Analysis, 2013–2017

  42. Latin America Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  43. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  44. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  45. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  46. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  47. Europe Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  48. Europe Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  49. Europe Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  50. Europe Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  51. Europe Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  52. Europe Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  53. U.K. Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  54. U.K. Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  55. France Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  56. France Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  57. Italy Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  58. Italy Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  59. Spain Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  60. Spain Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  61. Russia Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  62. Russia Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  63. Germany Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  64. Germany Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  65. Rest of Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  66. Rest of Europe Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  67. Europe Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  68. Europe Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  69. Europe Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  70. Europe Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  71. Europe Biologics Market Size (US$ Mn) Analysis, 2013–2017

  72. Europe Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  73. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  74. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  75. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  76. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  77. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  78. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  79. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  80. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  81. Asia Pacific Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  82. Asia Pacific Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  83. Japan Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  84. Japan Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  85. China Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  86. China Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  87. India Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  88. India Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  89. Australia Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  90. Australia Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  91. Rest of Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  92. Rest of Asia Pacific Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  93. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  94. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  95. Asia Pacific Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  96. Asia Pacific Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  97. Asia Pacific Biologics Market Size (US$ Mn) Analysis, 2013–2017

  98. Asia Pacific Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  99. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  100. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  101. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  102. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  103. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  104. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  105. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  106. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  107. Middle East & Africa Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  108. Middle East & Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  109. South Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  110. South Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  111. GCC Countries Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  112. GCC Countries Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  113. Rest of Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  114. Rest of Middle East & Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  115. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  116. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  117. Middle East & Africa Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  118. Middle East & Africa Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  119. Middle East & Africa Biologics Market Size (US$ Mn) Analysis, 2013–2017

  120. Middle East & Africa Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  121. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  122. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  123. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  124. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  125. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Region, 2018 & 2028

  126. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Region, 2018–2028

  127. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Region, 2018–2028

  128. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Product Type, 2018 & 2028

  129. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Product Type, 2018–2028

  130. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  131. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Route of Administration , 2018 & 2028

  132. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Route of Administration , 2018–2028

  133. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration , 2018–2028

  134. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Distribution Channel, 2018 & 2028

  135. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2018–2028

  136. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  137. Global Psoriatic Arthritis Treatment Market Value Analysis and Forecast, 2017–2028 (US$ Mn)

  138. Global Psoriatic Arthritis Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028

  1. North America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  2. North America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  3. North America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  4. North America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  5. Latin America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  6. Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  7. Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  8. Latin America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  9. Europe Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  10. Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  11. Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  12. Europe Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  13. Asia Pacific Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  14. Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  15. Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  16. Asia Pacific Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  17. Middle East & Africa Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  18. Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  19. Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  20. Middle East & Africa Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  21. Global Psoriatic Arthritis Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017

  22. Global Psoriatic Arthritis Treatment Market Size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

  23. Global Psoriatic Arthritis Treatment Market Size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration

  24. Global Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

To Learn More About our Comprehensive Perspective on Psoriatic Arthritis (PsA) Treatment Market Analysis, Contact Us

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Client Partner - Global Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology